Zhang's guidelines vs WHO guidelines for diagnosing labour dystocia
We read with interest the Labour Progression Study (LaPS) by Stine Bernitz and colleagues 1 , which reported no differences between Zhang's guidelines and WHO guide lines for diagnosing labour dystocia.
Since diagnostic criteria only affect progression of labour by subsequent interventions, knowledge of to what extent the diagnosis of labour dysto cia was followed by interventions is important. The protocol indicates that if labour dystocia is diagnosed according to either of the two guide lines, amniotomy would be performed followed by oxytocin. However, criteria for diagnosing failure to progress in labour, and the indications for intrapartum caesarean section (the primary outcome), are not sufficiently described.
Although labour dystocia was diagnosed less often in the WHO group than in the Zhang group (45·7% vs 47·4%), rupture of the membranes (37·0% vs 35·1%) and augmentation with oxytocin (47·2% vs 41·7%) inter ventions occurred most often in the WHO group.
Potential differences causally related to the use of the two partographs would be due to women in whom the WHO and Zhang partographs showed discordant results (ie, WHO guide lines diagnosed dystocia and Zhang guidelines did not, or vice versa). Therefore, before concluding that monitoring of the progression of labour with both partographs did not result in differences, a comparison of the outcomes limited to those women with socalled discordant findings is needed. 2 This comparison will clarify if the effect of the type of partograph used is as futile as the authors suggest, and if the study is powered enough to show any differences between the partographs in their effectiveness in diagnosing labour dystocia and preventing intrapartum caesarean sections. 3 AK and DLR report no conflicts of interest. BWM is supported by a National Health and Medical Research Council Practitioner Fellowship and reports personal fees from and consultancy for ObsEva, Merck, and Guerbet. 
